CD274 and neoplasm: As a result, oral Bifidobacterium treatment could enhance the effectiveness of ICIs, increase anti-tumor immunity, and maybe strengthen the therapeutic effect of immune checkpoint inhibitors such as CD47, PD-1/PDL-1, and CTLA4 inhibitors.